Who's on first? what's on second?

Editorial

D Feigal. Control Clin Trials. 2001 Apr.

. 2001 Apr;22(2):139-41.

doi: 10.1016/s0197-2456(01)00115-5.

No abstract available

Comment on

ACTG (AIDS Clinical Trials Group) 384: a strategy trial comparing consecutive treatments for HIV-1.
Smeaton LM, DeGruttola V, Robbins GK, Shafer RW. Smeaton LM, et al. Control Clin Trials. 2001 Apr;22(2):142-59. doi: 10.1016/s0197-2456(00)00126-4. Control Clin Trials. 2001. PMID: 11306153 Free PMC article. Clinical Trial.
An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial.
Initio Co-ordinating Committee. Initio Co-ordinating Committee. Control Clin Trials. 2001 Apr;22(2):160-75. doi: 10.1016/s0197-2456(00)00123-9. Control Clin Trials. 2001. PMID: 11306154 Clinical Trial.
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial.
MacArthur RD, Chen L, Mayers DL, Besch CL, Novak R, van den Berg-Wolf M, Yurik T, Peng G, Schmetter B, Brizz B, Abrams D; CPCRA 058 FIRST Trial Study Team. MacArthur RD, et al. Control Clin Trials. 2001 Apr;22(2):176-90. doi: 10.1016/s0197-2456(01)00111-8. Control Clin Trials. 2001. PMID: 11306155 Clinical Trial.